-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Harmony Biosciences Holdings Inc. (HRMY)
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA) PT Raised to $13 at Cantor Fitzgerald
-
-
-
-
-
-
-
Cantor Starts Xenon Pharma (XENE) at Overweight, 'X Marks the Spot for Kv-Driven Leading Ion Channel Neuro-Innovator'
-
-
-
-
-
-
-
Aptinyx (APTX) PT Lowered to $5 at Cantor Fitzgerald
-
-
-
-
-
-
-
UPDATE: Cantor Fitzgerald Starts Oramed Pharma (ORMP) at Overweight
-
-
-
-
-
-
-
Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference
-
413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

